NYSE$ASH
Ashland Inc · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
Ashland Inc reported a net loss of $742 million for Q3 2025 driven by a $706 million goodwill impairment.
Ashland posted sales of $463 million for the three months ended June 30, 2025, down from $544 million a year earlier. The company recorded an operating loss of $708 million and a net loss of $742 million after a $706 million goodwill impairment charge in Life Sciences and Specialty Additives. Diluted EPS from continuing operations was a loss of $15.70 per share.
- Q3 2025 sales fell 15% year-over-year to $463 million amid portfolio optimization and softer demand.
- Goodwill impairment of $706 million produced an operating loss of $708 million.
- Net loss totaled $742 million, or $16.21 per diluted share, including discontinued operations.
- Life Sciences and Specialty Additives segments were most affected by the impairment charges.
Headline financials
Revenue & EPS history
Ashland · Revenue · Quarterly
$463M
Revenue by segment
Ashland · $473M total across 4 segments · Q3 2025
- Life Sciences$162M—34.2%
- Personal Care$147M—31.1%
- Specialty Additives$131M—27.7%
- Intermediates$33M—7.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
-0.4%
Avg return
Earnings day
-0.7%
Avg return
5 days after
+0.8%
Avg return
30 days after
45%
29 / 64 earnings
Positive
+15.9%
Q1 2024
Best reaction
-10.2%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2026 | +8.4% | +6.3% | +17.7% | |
| Q1 2026 | -0.8% | +4.2% | -6.8% | |
| Q4 2025 | -1.0% | -1.3% | +15.5% | |
| Q2 2025 | -9.9% | -11.5% | -9.0% | |
| Q1 2025 | -9.8% | -14.4% | -14.5% | |
| Q4 2024 | -5.0% | -7.3% | -11.2% | |
| Q3 2024 | -3.2% | -6.5% | -7.4% | |
| Q2 2024 | -2.6% | -1.2% | +2.7% | |
| Q1 2024 | +15.9% | +13.4% | +15.9% | |
| Q4 2023 | -4.8% | +0.8% | +7.3% | |
| Q3 2023 | +0.1% | +1.3% | -6.9% | |
| Q2 2023 | -10.2% | -9.5% | -15.0% | |
| Q1 2023 | +1.5% | -1.4% | -3.8% | |
| Q4 2022 | +7.9% | +8.0% | +11.9% | |
| Q3 2022 | -2.5% | -4.3% | +1.5% | |
| Q2 2022 | +4.7% | +3.5% | +4.3% | |
| Q1 2022 | +1.2% | -0.8% | -5.9% | |
| Q4 2021 | +1.4% | +7.4% | +5.3% | |
| Q3 2021 | -3.9% | -3.1% | -2.3% | |
| Q2 2021 | -7.0% | -7.3% | +1.2% | |
| Q1 2021 | +1.3% | +2.3% | +3.0% | |
| Q4 2020 | -2.4% | +3.9% | -2.5% | |
| Q3 2020 | -2.5% | -5.2% | -5.1% | |
| Q2 2020 | -0.1% | +5.3% | +20.8% | |
| Q1 2020 | +1.1% | -1.8% | +0.8% | |
| Q4 2019 | -3.8% | -8.6% | -3.8% | |
| Q3 2019 | +0.0% | -3.5% | -8.7% | |
| Q2 2019 | -5.4% | -4.9% | -5.0% | |
| Q1 2019 | +2.7% | +2.0% | +1.8% | |
| Q4 2018 | +9.0% | +8.5% | +2.6% | |
| Q3 2018 | +2.5% | +3.9% | +2.6% | |
| Q2 2018 | +7.7% | +10.6% | +17.4% | |
| Q1 2018 | +0.3% | +2.0% | -2.2% | |
| Q4 2017 | -3.6% | -3.9% | +2.5% | |
| Q3 2017 | -2.4% | -2.3% | -4.5% | |
| Q2 2017 | -1.4% | -2.5% | +7.6% | |
| Q1 2017 | +2.1% | +2.2% | +4.6% | |
| Q4 2016 | -4.1% | -5.3% | +1.3% | |
| Q3 2016 | -6.4% | -6.7% | -4.3% | |
| Q2 2016 | -0.7% | — | — | |
| Q1 2016 | -1.9% | — | — | |
| Q4 2015 | -0.1% | — | — | |
| Q3 2015 | -3.2% | — | — | |
| Q2 2015 | -1.4% | — | — | |
| Q1 2015 | +1.3% | — | — | |
| Q4 2014 | +2.9% | — | — | |
| Q3 2014 | -5.1% | — | — | |
| Q2 2014 | +4.5% | — | — | |
| Q1 2014 | -1.0% | — | — | |
| Q4 2013 | -5.8% | — | — | |
| Q3 2013 | +0.4% | — | — | |
| Q2 2013 | -0.1% | — | — | |
| Q1 2013 | +6.9% | — | — | |
| Q4 2012 | +0.4% | — | — | |
| Q3 2012 | -0.4% | — | — | |
| Q2 2012 | +1.5% | — | — | |
| Q1 2012 | +1.3% | — | — | |
| Q4 2011 | -4.8% | — | — | |
| Q3 2011 | +4.0% | — | — | |
| Q2 2011 | +0.8% | — | — | |
| Q1 2010 | +3.1% | — | — | |
| Q4 2010 | -1.2% | — | — | |
| Q3 2010 | -5.7% | — | — | |
| Q2 2010 | +2.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro